Pediatrics & Neonatology
Volume 49, Issue 4 , Pages 103-112, August 2008

Enterovirus 71 in Taiwan

  • Luan-Yin Chang

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Pediatrics, National Taiwan University Hospital, College of Medicine, National Taiwan University, 7, Chung-Shan South Road, Taipei 10016, Taiwan

Department of Pediatrics, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan

Received 3 August 2007; received in revised form 7 July 2008; accepted 28 August 2008.

Article Outline

The enterovirus 71 (EV71) outbreak in Taiwan in 1998 proved fatal in many children. A seroepidemiological study performed prior to the 1998 outbreak showed pre-epidemic (1997) EV71 seroprevalence rates to be about 60–70% in adults and children older than 6 years of age. A retrospective case review carried out from 1980–81 identified 16 cases of hand, foot and mouth disease associated with central nervous system involvement, two of whom died soon after hospitalization. There were 405 severe cases and 78 deaths reported in the 1998 epidemic, and dozens of fatal EV71 cases were still reported from 2000 to 2002. A stage-based management strategy was developed to reduce fatality, but most survivors of brainstem encephalitis with cardio pulmonary failure have neurologic sequelae and impaired cognition. Continuous clinical and laboratory surveillance of EV71 disease is required to enable earlier implementation of control and prevention measures. Development of EV71-specific antiviral therapy, a novel class of imidazolidinones, and development of a vaccine are ongoing.

KEY WORDS:  antiviral drug , enterovirus 71 , hand , foot and mouth disease , management , population surveillance , Taiwan , transmission , vaccine

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Schmidt NJ , Lennette EH , Ho HH . An apparently new enterovirus isolated from patients with disease of the central nervous system . J Infect Dis . 1974;129:304–309
  2. Shindarov LM , Chumakov MP , Voroshilova MK , et al.   Epidemiological, clinical and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by entero virus 71 . J Hyg Epidemiol Microbiol Immunol . 1979;23:284–295
  3. Nagy G , Takatsy S , Kukan E , Mihaly I , Domok I . Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978 . Arch Virol . 1982;71:217–227
  4. Chan LG , Parashar UD , Lye MS , et al.   Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease . Clin Infect Dis . 2000;31:678–683
  5. Ho M , Chen ER , Hsu KH , et al.   An epidemic of enterovirus 71 infection in Taiwan . N Eng J Med . 1999;341:929–935
  6. Chang LY , CC King , KH Hsu , et al.   Risk factors of enterovirus 71 infection and associated hand-foot-mouth-disease/herpangina in children. Pediatrics 2002;109:e88. 7. Lu CY, Lee CY, Kao CL, et al. Incidence and case–fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan . J Med Virol . 2002;67:217–223
  7. Chu PY , Lin KH , Hwang KP , et al.   Molecular epidemiology of enterovirus 71 in Taiwan . Arch Virol . 2001;146:589–600
  8. Chang LY , Lee CY , Kao CL , et al.   Hand, foot and mouth disease complicated with central nervous system involvement in Taiwan in 1980-1981 . J Formos Med Assoc . 2007;106:173–176
  9. Wu TN , Tsai SF , Li SF , et al.   Sentinel surveillance of enterovirus 71, Taiwan, 1998 . Emerg Infect Dis . 1999;5:458–460
  10. Chen SC , Chang HL , Yan TR , Cheng YT , Chen KT . An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan . Am J Trop Med Hyg . 2007;77:188–191
  11. Taiwan CDC . Locations of 13 Contract Laboratories . Available at: http://www.cdc.gov.tw/index_info.asp?p_data_id_2=331&act=init [Date accessed: August 13, 2008]
  12. Chen KT , Chang HL , Wang ST , Cheng YT , Yang JY . Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005 . Pediatrics . 2007;120:e244–e252
  13. Chang LY , Lin TY , Huang YC , et al.   Comparison of enterovirus 71 and Coxsackievirus A16 clinical illness during the Taiwan enterovirus epidemic, 1998 . Ped Infect Dis J . 1999;18:1092–1096
  14. Gelfand HM , LeBlanc DR , Fox JP , Conwell DP . Studies on the development of natural immunity to poliomyelitis in Louisiana. II. Description and analysis of episodes of infection observed in study group households . Am J Hyg . 1957;65:367–385
  15. Kogon A , Spigland I , Frothingham TE , et al.   The Virus Watch program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in Coxsackie and echovirus infections . Am J Epidemiol . 1969;89:51–61
  16. Morens DM , Pallansch MA , Moore M . Polioviruses and other enteroviruses . In:  Belshe RB editors. Textbook of Human Virology . 2nd edition. St. Louis, MO: Mosby Yearbook; 1991;p. 427–497
  17. Chang LY , Tsao KC , Hsia SH , et al.   Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan . JAMA . 2004;291:222–227
  18. Chung PW , Huang YC , Chang LY , Lin TY , Ning HC . Duration of enterovirus shedding in stool . J Microbiol Immunol Infect . 2001;34:167–170
  19. Chang LY , Lin TY , Hsu KH , et al.   Clinical features and risk factors of pulmonary oedema after enterovirus 71-related hand, foot, and mouth disease . Lancet . 1999;354:1682–1686
  20. Chang LY , Hsia SH , Wu CT , et al.   Outcome of EV71 infections with or without stage-based management, 1998-2002 . Pediatr Infect Dis J . 2004;23:327–331
  21. Lin TY , Chang LY , Hsai SH , et al.   The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management . Clin Infect Dis . 2002;34:S52–S57
  22. Huang CC , Liu CC , Chang YC , Chen CY , Wang ST , Yeh TF . Neurologic complications in children with enterovirus 71 infection . N Engl J Med . 1999;341:936–942
  23. Hsueh C , Jung SM , Shih SR , et al.   Acute and fatal encephalomyelitis during an outbreak of enterovirus type 71 infection in Taiwan: report of an autopsy case with pathologic, immunofluorescence and molecular studies . Mod Pathol . 2000;13:1200–1205
  24. Lum LCS , Wong KT , Lam SK , et al.   Fatal enterovirus 71 encephalomyelitis . J Pediatr . 1998;133:795–798
  25. Lin TY , Chang LY , Huang YC , et al.   Different proinflammatory reactions in fatal and nonfatal enterovirus 71 infections: implications for early recognition and therapy . Acta Paediatr . 2002;91:632–635
  26. Wang SM , Lei HY , Huang KJ , et al.   Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema . J Infect Dis . 2003;188:564–570
  27. Lin TY , Hsia SH , Huang YC , Wu CT , Chang LY . Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system . Clin Infect Dis . 2003;36:269–274
  28. Yang KD , Yang MY , Li CC , et al.   Altered cellular but not humoral reactions in children with complicated ente rovirus 71 infections in Taiwan . J Infect Dis . 2001;183:850–856
  29. Chang LY , Hsiung CA , Lu CY , et al.   Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71 . Pediatr Res . 2006;60:466–471
  30. Chang LY , Huang LM , Gau SF , et al.   Neurodevelopment and cognition in children after enterovirus 71 infection . N Engl J Med . 2007;356:1226–1234
  31. Shih SR , Chen SJ , Hakimelahi GH , Liu HJ , Tseng CT , Shia KS . Selective human enterovirus and rhinovirus inhibitors: an overview of capsid-binding and protease-inhibiting molecules . Med Res Rev . 2004;24:449–474
  32. Groarke JM , Pevear DC . Attenuated virulence of pleconarilresistant Coxsackievirus B3 variants . J Infect Dis . 1999;179:1538–1541
  33. Shia KS , Li WT , Chang CM , et al.   Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors . J Med Chem . 2002;45:1644–1655
  34. Shih SR , Tsai MC , Tseng SN , et al.   Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone . Antimicrob Agents Chemother . 2004;48:3523–3529
  35. Chern JH , Shia KS , Hsu TA , et al.   Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors . Bioorg Med Chem Lett . 2004;14:2519–2525
  36. Taiwan CDC . Notifiable Infectious Diseases Statistics Systems: Severe Enteroviral Cases . Available at: http://nidss.cdc.gov.tw/singledisease.aspx?pt=s&dc=1&dt=3&disease=0749 [Date accessed: August 13, 2008]
  37. Yu CK , Chen CC , Chen CL , et al.   Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice . J Biomed Sci . 2000;7:523–528
  38. Wu CN , Lin YC , Fann C , Liao NS , Shih SR , Ho MS . Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus . Vaccine . 2001;20:895–904

PII: S1875-9572(08)60023-6

doi:10.1016/S1875-9572(08)60023-6

Pediatrics & Neonatology
Volume 49, Issue 4 , Pages 103-112, August 2008

Article Tools